SAN FRANCISCO, Feb. 8 /PRNewswire/ -- Synarc today announced that Gary Velasquez, President and CEO, is scheduled to speak at the UBS Global Healthcare Services Conference at the Grand Hyatt Hotel, New York, New York. Synarc’s presentation is planned for Tuesday, February 13, 2007 at 1:00 p.m. (Eastern Time).
Synarc is the world’s leading pharmaceutical service organization dedicated exclusively to global clinical trials providing imaging, molecular markers, and study participant recruitment services. Synarc has contributed to the approval of more leading compounds, across a broad spectrum of therapeutic areas, than any other central imaging provider. Synarc has sixteen offices around the world and currently manages over 200 clinical trials involving more than 200,000 patients. Synarc’s in-house radiologists and scientists are leading authorities in the use of medical imaging and molecular markers in drug development, and have pioneered many methods currently used in clinical trials. Our services include, study participant recruitment in emerging global markets, specializing in rapid enrollment with minimal dropout rates. We integrate all aspects of the design and execution of early to late phase clinical studies, including the centralized analysis of both standard and esoteric medical imaging and molecular markers. Synarc’s services span the spectrum of diseases including: Arthritis, Osteoporosis, Neurology, Orthopedics, Oncology and Cardiovascular disease. To learn more about our growing organization, visit our web site at: www.synarc.com.
Company Contact: Natalie Cummins - 201-213-1361 Synarc Inc. 575 Market Street 17th Floor San Francisco CA 94920 Company Information: www.Synarc.com
Synarc Inc.
CONTACT: Natalie Cummins of Synarc Inc., +1-201-213-1361
Web site: http://www.synarc.com//
